This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The South China University of Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Lianzhu Lin: Innovator in Antihyperuricemic Peptides
Introduction
Lianzhu Lin is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of biochemistry, particularly in the development of peptides with health benefits. His innovative work focuses on the preparation and application of saury Maillard peptides, which have shown promising antihyperuricemic activity.
Latest Patents
Lianzhu Lin holds a patent for a "Saury Maillard peptide and its preparation method and application." This invention discloses a method for creating a saury Maillard peptide that exhibits antihyperuricemic properties. The preparation process involves mincing saury, adding water, heating, and adjusting the pH to facilitate enzymatic reactions. The resulting peptide has been shown to significantly lower serum uric acid levels in animal studies, indicating its potential therapeutic benefits.
Career Highlights
Lianzhu Lin is affiliated with the South China University of Technology, where he conducts research and develops innovative solutions in the field of food science and technology. His work not only simplifies the production process of Maillard peptides but also enhances their efficacy, making them a valuable addition to health-related applications.
Collaborations
Lianzhu Lin has collaborated with notable colleagues, including Mouming Zhao and Qiangzhong Zhao. Their combined expertise has contributed to the advancement of research in peptide applications and their health benefits.
Conclusion
Lianzhu Lin's contributions to the field of biochemistry, particularly through his patented saury Maillard peptide, highlight the importance of innovation in developing health solutions. His work exemplifies the potential of peptides in addressing health issues such as hyperuricemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile